Although IGFBP3 is epigenetically suppressed in some cancers, with an apparent tumor suppressor role (34, 35), in other cancer types it shows high expression in association with high tumor grade and/or poor patient survival, although often the IGFBP-3 protein is located predominantly in the cytoplasm. Here, IGFBP3 is linked to neoplasm.